CARL (Carlsmed, Inc. Common Stock) Stock Analysis - Analyst Ratings

Carlsmed, Inc. Common Stock (CARL) is a publicly traded Healthcare sector company. As of May 21, 2026, CARL trades at $11.77 with a market cap of $297.13M and a P/E ratio of -5.59. CARL moved +4.07% today. Year to date, CARL is -2.65%; over the trailing twelve months it is flat. Its 52-week range spans $8.50 to $17.19. Analyst consensus is strong buy with an average price target of $18.40. Rallies surfaces CARL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CARL?

5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $18.40.

CARL Key Metrics

Key financial metrics for CARL
MetricValue
Price$11.77
Market Cap$297.13M
P/E Ratio-5.59
EPS$-2.12
Dividend Yield0.00%
52-Week High$17.19
52-Week Low$8.50
Volume0
Avg Volume0
Revenue (TTM)$50.51M
Net Income$-29.63M
Gross Margin75.31%

CARL Analyst Consensus

5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.40.

Latest CARL News

Recent CARL Insider Trades

  • Cordonnier Michael sold 197.85K (~$2.63M) on Mar 2, 2026.
  • B CAPITAL GROUP MANAGEMENT, L.P. bought 1.33M (~$20.00M) on Jul 24, 2025.
  • Sidow Kevin bought 13.33K (~$200.00K) on Jul 24, 2025.

Common questions about CARL

What do analysts rate CARL?
5 analysts cover CARL: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $18.40.
Does Rallies show CARL price targets?
Yes. Rallies tracks CARL analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CARL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CARL. It does not provide personalized investment advice.
CARL

CARL